LSD抗抑郁药试验数据亮眼，Lime申请IPO，可口可乐与IRS税务纠纷

This is Bloomberg Money Minute. Stocks are mixed as SpaceX weighs on sentiment about tech. Tiffany M Therapeutics shares surging late stage trial data showing groundbreaking results in the psychedelic drug developers experimental treatment for major depressive disorders. Analysts say the biotech LSD pill could also treat generalized anxiety disorder. Hoover backed electric bike firm known as lime seeking 80.9 million IPO line could have a market value of .7 billion.

Coca-Cola and the IRS, reportedly in dispute over whether the company reports too much profit it brought into little in the U.S.. Wall Street Journal says a federal appeals court in Miami will decide the case this week, and CBO says it will start to take part in the federal government's Medicare GLP one bridge program, meaning eligible Medicare beneficiaries will be able to obtain certain GLP one medicines for 50 bucks a month.

CBS also launching a new $49 minute clinic virtual visit. Who can prescribe these weight loss drugs? Denise Pellegrini Bloomberg.